Cargando…
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth
Phage therapy is the use of bacterial viruses as antibacterial agents. A primary consideration for commercial development of phages for phage therapy is the number of different bacterial strains that are successfully targeted, as this defines the breadth of a phage cocktail’s spectrum of activity. A...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541335/ https://www.ncbi.nlm.nih.gov/pubmed/34681243 http://dx.doi.org/10.3390/ph14101019 |
_version_ | 1784589204695547904 |
---|---|
author | Abedon, Stephen T. Danis-Wlodarczyk, Katarzyna M. Wozniak, Daniel J. |
author_facet | Abedon, Stephen T. Danis-Wlodarczyk, Katarzyna M. Wozniak, Daniel J. |
author_sort | Abedon, Stephen T. |
collection | PubMed |
description | Phage therapy is the use of bacterial viruses as antibacterial agents. A primary consideration for commercial development of phages for phage therapy is the number of different bacterial strains that are successfully targeted, as this defines the breadth of a phage cocktail’s spectrum of activity. Alternatively, phage cocktails may be used to reduce the potential for bacteria to evolve phage resistance. This, as we consider here, is in part a function of a cocktail’s ‘depth’ of activity. Improved cocktail depth is achieved through inclusion of at least two phages able to infect a single bacterial strain, especially two phages against which bacterial mutation to cross resistance is relatively rare. Here, we consider the breadth of activity of phage cocktails while taking both depth of activity and bacterial mutation to cross resistance into account. This is done by building on familiar algorithms normally used for determination solely of phage cocktail breadth of activity. We show in particular how phage cocktails for phage therapy may be rationally designed toward enhancing the number of bacteria impacted while also reducing the potential for a subset of those bacteria to evolve phage resistance, all as based on previously determined phage properties. |
format | Online Article Text |
id | pubmed-8541335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85413352021-10-24 Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth Abedon, Stephen T. Danis-Wlodarczyk, Katarzyna M. Wozniak, Daniel J. Pharmaceuticals (Basel) Opinion Phage therapy is the use of bacterial viruses as antibacterial agents. A primary consideration for commercial development of phages for phage therapy is the number of different bacterial strains that are successfully targeted, as this defines the breadth of a phage cocktail’s spectrum of activity. Alternatively, phage cocktails may be used to reduce the potential for bacteria to evolve phage resistance. This, as we consider here, is in part a function of a cocktail’s ‘depth’ of activity. Improved cocktail depth is achieved through inclusion of at least two phages able to infect a single bacterial strain, especially two phages against which bacterial mutation to cross resistance is relatively rare. Here, we consider the breadth of activity of phage cocktails while taking both depth of activity and bacterial mutation to cross resistance into account. This is done by building on familiar algorithms normally used for determination solely of phage cocktail breadth of activity. We show in particular how phage cocktails for phage therapy may be rationally designed toward enhancing the number of bacteria impacted while also reducing the potential for a subset of those bacteria to evolve phage resistance, all as based on previously determined phage properties. MDPI 2021-10-03 /pmc/articles/PMC8541335/ /pubmed/34681243 http://dx.doi.org/10.3390/ph14101019 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Opinion Abedon, Stephen T. Danis-Wlodarczyk, Katarzyna M. Wozniak, Daniel J. Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth |
title | Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth |
title_full | Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth |
title_fullStr | Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth |
title_full_unstemmed | Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth |
title_short | Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth |
title_sort | phage cocktail development for bacteriophage therapy: toward improving spectrum of activity breadth and depth |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541335/ https://www.ncbi.nlm.nih.gov/pubmed/34681243 http://dx.doi.org/10.3390/ph14101019 |
work_keys_str_mv | AT abedonstephent phagecocktaildevelopmentforbacteriophagetherapytowardimprovingspectrumofactivitybreadthanddepth AT daniswlodarczykkatarzynam phagecocktaildevelopmentforbacteriophagetherapytowardimprovingspectrumofactivitybreadthanddepth AT wozniakdanielj phagecocktaildevelopmentforbacteriophagetherapytowardimprovingspectrumofactivitybreadthanddepth |